Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1949 1
1951 1
1952 1
1957 1
1958 1
1959 2
1960 1
1961 1
1963 1
1964 3
1965 2
1966 9
1967 7
1968 2
1969 5
1970 5
1971 8
1972 6
1973 6
1974 4
1975 5
1976 15
1977 15
1978 17
1979 16
1980 24
1981 12
1982 13
1983 21
1984 15
1985 12
1986 7
1987 12
1988 13
1989 10
1990 15
1991 14
1992 11
1993 10
1994 16
1995 17
1996 12
1997 12
1998 10
1999 8
2000 12
2001 11
2002 11
2003 15
2004 15
2005 10
2006 15
2007 21
2008 12
2009 11
2010 10
2011 8
2012 7
2013 11
2014 5
2015 3
2016 2
2017 6
2018 4
2019 3
2020 5
2021 2
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

601 results

Results by year

Filters applied: . Clear all
Page 1
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, Kulke MH, Baird RD, Prabhu JS, Carbone D, Pecoraro C, Teh DBL, Sethi G, Cavalieri V, Lin KH, Javidi-Sharifi NR, Toska E, Davids MS, Brown JR, Diana P, Stebbing J, Fruman DA, Kumar AP. Glaviano A, et al. Among authors: jones rh. Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6. Mol Cancer. 2023. PMID: 37596643 Free PMC article. Review.
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.
Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL; STICHES Investigators. Velazquez EJ, et al. Among authors: jones rh. N Engl J Med. 2016 Apr 21;374(16):1511-20. doi: 10.1056/NEJMoa1602001. Epub 2016 Apr 3. N Engl J Med. 2016. PMID: 27040723 Free PMC article. Clinical Trial.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial.
Howell SJ, Casbard A, Carucci M, Ingarfield K, Butler R, Morgan S, Meissner M, Bale C, Bezecny P, Moon S, Twelves C, Venkitaraman R, Waters S, de Bruin EC, Schiavon G, Foxley A, Jones RH. Howell SJ, et al. Among authors: jones rh. Lancet Oncol. 2022 Jul;23(7):851-864. doi: 10.1016/S1470-2045(22)00284-4. Epub 2022 Jun 4. Lancet Oncol. 2022. PMID: 35671774 Free PMC article. Clinical Trial.
Coronary-artery bypass surgery in patients with left ventricular dysfunction.
Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL; STICH Investigators. Velazquez EJ, et al. Among authors: jones rh. N Engl J Med. 2011 Apr 28;364(17):1607-16. doi: 10.1056/NEJMoa1100356. Epub 2011 Apr 4. N Engl J Med. 2011. PMID: 21463150 Free PMC article. Clinical Trial.
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results.
Carson P, Wertheimer J, Miller A, O'Connor CM, Pina IL, Selzman C, Sueta C, She L, Greene D, Lee KL, Jones RH, Velazquez EJ; STICH Investigators. Carson P, et al. Among authors: jones rh. JACC Heart Fail. 2013 Oct;1(5):400-8. doi: 10.1016/j.jchf.2013.04.012. Epub 2013 Sep 11. JACC Heart Fail. 2013. PMID: 24621972 Free PMC article. Clinical Trial.
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
de Bono JS, Concin N, Hong DS, Thistlethwaite FC, Machiels JP, Arkenau HT, Plummer R, Jones RH, Nielsen D, Windfeld K, Ghatta S, Slomovitz BM, Spicer JF, Yachnin J, Ang JE, Mau-Sørensen PM, Forster MD, Collins D, Dean E, Rangwala RA, Lassen U. de Bono JS, et al. Among authors: jones rh. Lancet Oncol. 2019 Mar;20(3):383-393. doi: 10.1016/S1470-2045(18)30859-3. Epub 2019 Feb 8. Lancet Oncol. 2019. PMID: 30745090 Clinical Trial.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial.
Jones RH, Casbard A, Carucci M, Cox C, Butler R, Alchami F, Madden TA, Bale C, Bezecny P, Joffe J, Moon S, Twelves C, Venkitaraman R, Waters S, Foxley A, Howell SJ. Jones RH, et al. Lancet Oncol. 2020 Mar;21(3):345-357. doi: 10.1016/S1470-2045(19)30817-4. Epub 2020 Feb 5. Lancet Oncol. 2020. PMID: 32035020 Free PMC article. Clinical Trial.
Hepatoselectivity and the evolution of insulin.
Herring R, Jones RH, Russell-Jones DL. Herring R, et al. Among authors: jones rh. Diabetes Obes Metab. 2014 Jan;16(1):1-8. doi: 10.1111/dom.12117. Epub 2013 May 16. Diabetes Obes Metab. 2014. PMID: 23679086 Review.
The global primary care crisis.
Jones RH. Jones RH. Br J Gen Pract. 2023 Feb 23;73(728):108. doi: 10.3399/bjgp23X732081. Print 2023 Mar. Br J Gen Pract. 2023. PMID: 36823070 Free PMC article. No abstract available.
601 results